Press "Enter" to skip to content

Exclusive Report on Blood Glucose Monitoring Market 2019 | Industry Drivers, Business Plans, Types, Applications, Challenges, Opportunities and Latest Trends Forecast to 2024

Blood

The “Blood Glucose Monitoring Market” research report 2019 delivers comprehensive information about the market ranging from the establishment to the predictable growth trend. Blood Glucose Monitoring market report provides brief analytical data of the market contenders globally using advanced methodological approaches, such as SWOT analysis, production chain, cost, sales margin, financial details, recent developments. Blood Glucose Monitoring market report also offers market competitors that includes detailed company profiles along with company product specifications.

Market Overview:

  • The global blood glucose monitoring market is expected to register a CAGR of 11.88% during the forecast period of 2019 – 2024; the market is estimated to reach USD 12.8 billion by 2019.
  • Blood glucose monitoring devices are used for effective diabetes diagnosis and treatment. A rise in the diabetic population drives the market by increasing the use of blood glucose monitoring devices.
  • Obesity is also considered as one of the major factors contributing to the disease, primarily Type 2 diabetes.
  • Also, other factors, such as technological innovations and advancements, give much convenience in measuring the blood glucose levels. One such advancement in monitoring the blood glucose level is established with continuous glucose monitoring devices.
  • These devices help in the early detection of hypo and hyperglycemic conditions, which tend to drive the market for glucose monitoring.

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14245404

    In Blood Glucose Monitoring Market Report, Following Companies Are Covered:

  • Abbott Diabetes Care
  • Roche
  • Johnson & Johnson
  • Dexcom
  • Medtronic
  • Arkray
  • Ascensia Diabetes Care
  • Agamatrix Inc.
  • Bionime Corporation
  • Acon
  • Medisana
  • Trivida
  • Rossmax

    Blood Glucose Monitoring Market 2019 report will help the industry aspirants in arranging their strategies. The measurements offered in this report will be an exact and helpful manual to shape the business development. Additionally, will Provide historical data along with a future forecast and detailed analysis and also expected opportunities.

    Scope of the Report:

  • There are two main types of blood glucose monitoring devices included in this study, namely the self monitoring blood glucose devices and the continuous glucose monitoring devices. The devices are further categorized by components, i.e. the self-monitoring blood glucose (SMBG) devices are segmented into glucometer devices, test strips, and lancets (which are further studied by their usage in hospital and home individually) and continuous glucose monitoring (CGM) devices are segmented into sensors and receivers.

    Reasons for Buying Blood Glucose Monitoring Market Report:

    • This report provides pin-point analysis for changing competitive dynamics
    • It provides a forward looking perspective on different factors driving or restraining market growth
    • It provides a five-year forecast assessed on the basis of how the market is predicted to grow
    • It helps in understanding the key product segments and their future
    • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
    • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

    For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/14245404

    Key Market Trends: – Glucometer consumables (test strips and lancets) occupy the highest market share

    Although CGM is an advanced way for people living with diabetes to check glucose readings in real-time, SMBG is the most preferred device by the patients due to its economic affordability and less sophisticated usage when compared to CGM. The SBGM occupies more than 87% of the share in the blood glucose monitoring market. The further segmented market of SBGM gives an understanding that the disposable consumables – test strips and lancets, occupy the larger market share when compared to glucometer devices. However, the CAGR for glucometer devices is high.
    CGM, though it provides real-time data of blood glucose levels for patients, has low adaptability in the emerging markets. However, CGM’s adaptability is high in developed markets. The cost factor is a major concern for the low growth of CGM in emerging markets.

    North America is leading the market

    In 2018, North America, especially the United States, held the largest share in the blood glucose monitoring market, due to the large patient pool and wide acceptance of advanced technologies followed by Europe, which showed moderate growth. Asia-Pacific, Latin America, and the Middle East & Africa showed low growth due to economic affordability.

    The Research Document Will Answer Following Questions Such as:

    • What are the cutting-edge technologies responsible for driving the growth of the market?
    • What are the main applications of the market? What are the growth prospects to the market applications into the market?
    • At what stage of development are the key market products?
    • What are the shortcomings that has to face to become commercially viable? Is their growth and commercialization dependent on cost declines or technological/application breakthroughs?
    • What is the outlook for the industry?
    • What difference does performance characteristics of Blood Glucose Monitoring create from those of established entities?

    Purchase this Report (Price 5000 USD for single user license) – https://www.industryresearch.co/purchase/14245404

    Detailed TOC of Blood Glucose Monitoring Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Drivers
    4.3 Restraints
    4.4 Porter’s Five Forces Analysis
    4.4.1 Bargaining Power of Suppliers
    4.4.2 Bargaining Power of Consumers
    4.4.3 Threat of New Entrants
    4.4.4 Threat of Substitute Products and Services
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 Blood Glucose Monitoring
    5.1.1 Self-Monitoring Blood Glucose
    5.1.1.1 By Component (Market Size, Value and Volume)
    5.1.1.1.1 Glucometer Devices
    5.1.1.1.2 Test Strips
    5.1.1.1.3 Lancets
    5.1.1.2 By End User
    5.1.1.2.1 Hospital (Market Size, Value and Volume)
    5.1.1.2.1.1 Glucometer Devices
    5.1.1.2.1.2 Test Strips
    5.1.1.2.1.3 Lancets
    5.1.1.2.2 Personal (Market Size, Value and Volume)
    5.1.1.2.2.1 Glucometer Devices
    5.1.1.2.2.2 Test Strips
    5.1.1.2.2.3 Lancets
    5.1.2 Continuous Blood Glucose Monitoring
    5.1.2.1 By Component (Market Size, Value and Volume)
    5.1.2.1.1 Sensors
    5.1.2.1.2 Receivers
    5.2 Geography
    5.2.1 North America
    5.2.1.1 United States (Market Size, Value and Volume)
    5.2.1.1.1 Self-Monitoring Blood Glucose
    5.2.1.1.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.1.1.1.2 By End User (Hospital and Home)
    5.2.1.1.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.1.1.2 Continuous Glucose Monitoring
    5.2.1.1.2.1 By Component (Sensors and Receivers)
    5.2.1.1.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.1.2 Canada (Market Size, Value and Volume)
    5.2.1.2.1 Self-Monitoring Blood Glucose
    5.2.1.2.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.1.2.1.2 By End User (Hospital and Home)
    5.2.1.2.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.1.2.2 Continuous Glucose Monitoring
    5.2.1.2.2.1 By Component (Sensors and Receivers)
    5.2.1.2.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.1.3 Rest of North America (Market Size, Value and Volume)
    5.2.1.3.1 Self-Monitoring Blood Glucose
    5.2.1.3.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.1.3.1.2 By End User (Hospital and Home)
    5.2.1.3.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.1.3.2 Continuous Glucose Monitoring
    5.2.1.3.2.1 By Component (Sensors and Receivers)
    5.2.1.3.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.2 Europe
    5.2.2.1 France (Market Size, Value and Volume)
    5.2.2.1.1 Self-Monitoring Blood Glucose
    5.2.2.1.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.2.1.1.2 By End User (Hospital and Home)
    5.2.2.1.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.2.1.2 Continuous Glucose Monitoring
    5.2.2.1.2.1 By Component (Sensors and Receivers)
    5.2.2.1.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.2.2 Germany (Market Size, Value and Volume)
    5.2.2.2.1 Self-Monitoring Blood Glucose
    5.2.2.2.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.2.2.1.2 By End User (Hospital and Home)
    5.2.2.2.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.2.2.2 Continuous Glucose Monitoring
    5.2.2.2.2.1 By Component (Sensors and Receivers)
    5.2.2.2.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.2.3 Italy (Market Size, Value and Volume)
    5.2.2.3.1 Self-Monitoring Blood Glucose
    5.2.2.3.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.2.3.1.2 By End User (Hospital and Home)
    5.2.2.3.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.2.3.2 Continuous Glucose Monitoring
    5.2.2.3.2.1 By Component (Sensors and Receivers)
    5.2.2.3.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.2.4 Spain (Market Size, Value and Volume)
    5.2.2.4.1 Self-Monitoring Blood Glucose
    5.2.2.4.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.2.4.1.2 By End User (Hospital and Home)
    5.2.2.4.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.2.4.2 Continuous Glucose Monitoring
    5.2.2.4.2.1 By Component (Sensors and Receivers)
    5.2.2.4.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.2.5 United Kingdom (Market Size, Value and Volume)
    5.2.2.5.1 Self-Monitoring Blood Glucose
    5.2.2.5.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.2.5.1.2 By End User (Hospital and Home)
    5.2.2.5.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.2.5.2 Continuous Glucose Monitoring
    5.2.2.5.2.1 By Component (Sensors and Receivers)
    5.2.2.5.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.2.6 Russia (Market Size, Value and Volume)
    5.2.2.6.1 Self-Monitoring Blood Glucose
    5.2.2.6.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.2.6.1.2 By End User (Hospital and Home)
    5.2.2.6.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.2.6.2 Continuous Glucose Monitoring
    5.2.2.6.2.1 By Component (Sensors and Receivers)
    5.2.2.6.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.2.7 Rest of Europe (Market Size, Value and Volume)
    5.2.2.7.1 Self-Monitoring Blood Glucose
    5.2.2.7.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.2.7.1.2 By End User (Hospital and Home)
    5.2.2.7.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.2.7.2 Continuous Glucose Monitoring
    5.2.2.7.2.1 By Component (Sensors and Receivers)
    5.2.2.7.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.3 Latin America
    5.2.3.1 Mexico (Market Size, Value and Volume)
    5.2.3.1.1 Self-Monitoring Blood Glucose
    5.2.3.1.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.3.1.1.2 By End User (Hospital and Home)
    5.2.3.1.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.3.1.2 Continuous Glucose Monitoring
    5.2.3.1.2.1 By Component (Sensors and Receivers)
    5.2.3.1.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.3.2 Brazil (Market Size, Value and Volume)
    5.2.3.2.1 Self-Monitoring Blood Glucose
    5.2.3.2.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.3.2.1.2 By End User (Hospital and Home)
    5.2.3.2.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.3.2.2 Continuous Glucose Monitoring
    5.2.3.2.2.1 By Component (Sensors and Receivers)
    5.2.3.2.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.3.3 Rest of Latin America (Market Size, Value and Volume)
    5.2.3.3.1 Self-Monitoring Blood Glucose
    5.2.3.3.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.3.3.1.2 By End User (Hospital and Home)
    5.2.3.3.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.3.3.2 Continuous Glucose Monitoring
    5.2.3.3.2.1 By Component (Sensors and Receivers)
    5.2.3.3.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.4 Asia-Pacific
    5.2.4.1 Japan (Market Size, Value and Volume)
    5.2.4.1.1 Self-Monitoring Blood Glucose
    5.2.4.1.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.4.1.1.2 By End User (Hospital and Home)
    5.2.4.1.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.1.2 Continuous Glucose Monitoring
    5.2.4.1.2.1 By Component (Sensors and Receivers)
    5.2.4.1.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.4.2 South Korea (Market Size, Value and Volume)
    5.2.4.2.1 Self-Monitoring Blood Glucose
    5.2.4.2.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.4.2.1.2 By End User (Hospital and Home)
    5.2.4.2.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.2.2 Continuous Glucose Monitoring
    5.2.4.2.2.1 By Component (Sensors and Receivers)
    5.2.4.2.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.4.3 China (Market Size, Value and Volume)
    5.2.4.3.1 Self-Monitoring Blood Glucose
    5.2.4.3.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.4.3.1.2 By End User (Hospital and Home)
    5.2.4.3.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.3.2 Continuous Glucose Monitoring
    5.2.4.3.2.1 By Component (Sensors and Receivers)
    5.2.4.3.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.4.4 India (Market Size, Value and Volume)
    5.2.4.4.1 Self-Monitoring Blood Glucose
    5.2.4.4.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.4.4.1.2 By End User (Hospital and Home)
    5.2.4.4.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.4.2 Continuous Glucose Monitoring
    5.2.4.4.2.1 By Component (Sensors and Receivers)
    5.2.4.4.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.4.5 Australia (Market Size, Value and Volume)
    5.2.4.5.1 Self-Monitoring Blood Glucose
    5.2.4.5.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.4.5.1.2 By End User (Hospital and Home)
    5.2.4.5.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.5.2 Continuous Glucose Monitoring
    5.2.4.5.2.1 By Component (Sensors and Receivers)
    5.2.4.5.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.4.6 Vietnam (Market Size, Value and Volume)
    5.2.4.6.1 Self-Monitoring Blood Glucose
    5.2.4.6.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.4.6.1.2 By End User (Hospital and Home)
    5.2.4.6.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.6.2 Continuous Glucose Monitoring
    5.2.4.6.2.1 By Component (Sensors and Receivers)
    5.2.4.6.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.4.7 Malaysia (Market Size, Value and Volume)
    5.2.4.7.1 Self-Monitoring Blood Glucose
    5.2.4.7.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.4.7.1.2 By End User (Hospital and Home)
    5.2.4.7.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.7.2 Continuous Glucose Monitoring
    5.2.4.7.2.1 By Component (Sensors and Receivers)
    5.2.4.7.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.4.8 Indonesia (Market Size, Value and Volume)
    5.2.4.8.1 Self-Monitoring Blood Glucose
    5.2.4.8.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.4.8.1.2 By End User (Hospital and Home)
    5.2.4.8.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.8.2 Continuous Glucose Monitoring
    5.2.4.8.2.1 By Component (Sensors and Receivers)
    5.2.4.8.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.4.9 Philippines (Market Size, Value and Volume)
    5.2.4.9.1 Self-Monitoring Blood Glucose
    5.2.4.9.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.4.9.1.2 By End User (Hospital and Home)
    5.2.4.9.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.9.2 Continuous Glucose Monitoring
    5.2.4.9.2.1 By Component (Sensors and Receivers)
    5.2.4.9.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.4.10 Thailand (Market Size, Value and Volume)
    5.2.4.10.1 Self-Monitoring Blood Glucose
    5.2.4.10.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.4.10.1.2 By End User (Hospital and Home)
    5.2.4.10.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.10.2 Continuous Glucose Monitoring
    5.2.4.10.2.1 By Component (Sensors and Receivers)
    5.2.4.10.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.4.11 Rest of Asia-Pacific (Market Size, Value and Volume)
    5.2.4.11.1 Self-Monitoring Blood Glucose
    5.2.4.11.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.4.11.1.2 By End User (Hospital and Home)
    5.2.4.11.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.11.2 Continuous Glucose Monitoring
    5.2.4.11.2.1 By Component (Sensors and Receivers)
    5.2.4.11.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.5 Middle East and Africa
    5.2.5.1 Saudi Arabia (Market Size, Value and Volume)
    5.2.5.1.1 Self-Monitoring Blood Glucose
    5.2.5.1.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.5.1.1.2 By End User (Hospital and Home)
    5.2.5.1.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.5.1.2 Continuous Glucose Monitoring
    5.2.5.1.2.1 By Component (Sensors and Receivers)
    5.2.5.1.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.5.2 Iran (Market Size, Value and Volume)
    5.2.5.2.1 Self-Monitoring Blood Glucose
    5.2.5.2.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.5.2.1.2 By End User (Hospital and Home)
    5.2.5.2.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.5.2.2 Continuous Glucose Monitoring
    5.2.5.2.2.1 By Component (Sensors and Receivers)
    5.2.5.2.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.5.3 Egypt (Market Size, Value and Volume)
    5.2.5.3.1 Self-Monitoring Blood Glucose
    5.2.5.3.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.5.3.1.2 By End User (Hospital and Home)
    5.2.5.3.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.5.3.2 Continuous Glucose Monitoring
    5.2.5.3.2.1 By Component (Sensors and Receivers)
    5.2.5.3.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.5.4 Oman (Market Size, Value and Volume)
    5.2.5.4.1 Self-Monitoring Blood Glucose
    5.2.5.4.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.5.4.1.2 By End User (Hospital and Home)
    5.2.5.4.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.5.4.2 Continuous Glucose Monitoring
    5.2.5.4.2.1 By Component (Sensors and Receivers)
    5.2.5.4.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.5.5 South Africa (Market Size, Value and Volume)
    5.2.5.5.1 Self-Monitoring Blood Glucose
    5.2.5.5.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.5.5.1.2 By End User (Hospital and Home)
    5.2.5.5.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.5.5.2 Continuous Glucose Monitoring
    5.2.5.5.2.1 By Component (Sensors and Receivers)
    5.2.5.5.2.2 By Company (Dexcom, Abbott, Medtronic and Others)
    5.2.5.6 Rest of Middle and Africa (Market Size, Value and Volume)
    5.2.5.6.1 Self-Monitoring Blood Glucose
    5.2.5.6.1.1 By Component (Glucometer Device, Test strips, Lancets)
    5.2.5.6.1.2 By End User (Hospital and Home)
    5.2.5.6.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.5.6.2 Continuous Glucose Monitoring
    5.2.5.6.2.1 By Component (Sensors and Receivers)
    5.2.5.6.2.2 By Company (Dexcom, Abbott, Medtronic and Others)

    6 MARKET INDICATORS
    6.1 Type-1 Diabetes population (2013-2024)
    6.2 Type-2 Diabetes population (2013-2024)

    7 COMPETITIVE LANDSCAPE
    7.1 COMPANY PROFILES
    7.1.1 Abbott Diabetes Care
    7.1.2 Roche
    7.1.3 Johnson & Johnson
    7.1.4 Dexcom
    7.1.5 Medtronic
    7.1.6 Arkray
    7.1.7 Ascensia Diabetes Care
    7.1.8 Agamatrix Inc.
    7.1.9 Bionime Corporation
    7.1.10 Acon
    7.1.11 Medisana
    7.1.12 Trivida
    7.1.13 Rossmax
    7.2 COMPANY SHARE ANALYSIS
    7.2.1 Roche
    7.2.2 Johnson & Johnson
    7.2.3 Abbott Diabetes Care
    7.2.4 Dexcom
    7.2.5 Medtronic
    7.2.6 Others

    8 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Blood Culture Test Industry: Global Market Overview, Shares, Growth, Demand, market Size, Production, Types & Applications and Forecast Report 2024

    Global Instant Dry Yeast Market 2019: Industry Size & Share, Business Strategies, Growth Analysis, Regional Demand, Revenue, Key Manufacturers and 2026 Forecast Research Report

    Condensing Unit Market 2019 Analysis and Outlook, Demand, Industry Size, Future Trends and Industry Growth Research Report 2025

    Cosmetic Tubes Market Size 2019 – Global Industry Share, Comprehensive Study, Trends, Demand Status, and Regional Forecast to 2023